End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.23 INR | -2.02% | +10.51% | -15.62% |
May. 30 | Lasa Supergenerics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Apr. 26 | Lasa Supergenerics CFO Steps Down | MT |
Business Summary
Number of employees: 89
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredient Bulk Drugs Products
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 16-03-10 | |
Sunil Sitale
ADM | Chief Administrative Officer | - | - |
Compliance Officer | 37 | 23-03-20 | |
Hitesh Wadhwani
LAW | General Counsel | - | - |
Vijay Bhat
SAM | Sales & Marketing | - | 10-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 16-03-10 | |
Director/Board Member | 63 | 17-05-01 | |
Director/Board Member | 35 | 17-05-01 | |
Director/Board Member | - | 17-05-01 | |
Director/Board Member | - | 17-05-01 | |
Director/Board Member | - | 18-02-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,101,239 | 18,022,513 ( 35.97 %) | 0 | 35.97 % |
Company contact information
Lasa Supergenerics Ltd.
Office No: 705, Minerva Estate A Wing, 02 Commercial Tower
400080, Mumbai
+
Sector
1st Jan change | Capi. | |
---|---|---|
-15.62% | 15.14M | |
-11.72% | 79.5B | |
+22.75% | 3.62B | |
-3.20% | 3.15B | |
+18.58% | 1.74B | |
-8.59% | 1.2B | |
-38.07% | 1.02B | |
-40.81% | 986M | |
-35.77% | 836M | |
-9.04% | 833M |
- Stock Market
- Equities
- LASA Stock
- Company Lasa Supergenerics Limited